| http://www.w3.org/ns/prov#value | - The new therapeutic aims to overcome current barriers which make it exceptionally difficult for antibodies to be used to treat brain diseases such as Alzheimer's disease and brain tumours - diseases which are becoming more widespread in the population, with half a million sufferers of Alzheimer's disease in the UK alone.
|
